Sunflower Pharmaceutical Group Co.,Ltd (SHE:002737)
China flag China · Delayed Price · Currency is CNY
12.44
+0.28 (2.30%)
Jun 12, 2026, 3:04 PM CST

SHE:002737 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,471852.821,0402,2872,3991,320
Short-Term Investments
-----304.42
Trading Asset Securities
1,2031,7551,2581,3151,449668.69
Cash & Short-Term Investments
2,6742,6082,2983,6023,8472,293
Cash Growth
11.40%13.47%-36.19%-6.38%67.77%27.52%
Accounts Receivable
131.82182.31584.93110.13184.25268.98
Other Receivables
10.578.8214.9541.4242.5712.21
Receivables
142.39191.13599.88151.56226.82281.19
Inventory
654.05617.43867.31873.19632.08709.64
Prepaid Expenses
-11.5431.6844.33.748.75
Other Current Assets
91.873.6188.23116.81151.03100.11
Total Current Assets
3,5623,5023,8864,7884,8613,393
Property, Plant & Equipment
1,1871,2081,3111,4351,4971,577
Long-Term Investments
7894.8897.12122.44141.38131.32
Goodwill
56.4456.4486.9891.7791.77107.6
Other Intangible Assets
307.95312.73332.64345.37366.52337.77
Long-Term Deferred Tax Assets
65.7864.1537.6258.9256.5155.78
Long-Term Deferred Charges
5.656.7510.038.866.811.87
Other Long-Term Assets
92.4383.964.8931.3910.8530.77
Total Assets
5,3565,3285,8266,8827,0325,635
Accounts Payable
411.75421.62319.05734.6714.48547.18
Accrued Expenses
74.13136.84205.55233.76301.01124.75
Short-Term Debt
105108.490.0214.43420200
Current Portion of Leases
-4.444.954.465.593.5
Current Income Taxes Payable
41.085.964.7387.5360.2143.54
Current Unearned Revenue
230.61272.57285.68297.32551.54167.04
Other Current Liabilities
201.45201.6207.55147.8122.54166.6
Total Current Liabilities
1,0681,1521,0281,5202,1751,253
Long-Term Debt
-----33.57
Long-Term Leases
1.5934.037.6210.57.01
Long-Term Unearned Revenue
175.26178.83199.37342.08397.26389.08
Long-Term Deferred Tax Liabilities
2.593.014.957.619.8917.82
Other Long-Term Liabilities
1.31.3----
Total Liabilities
1,2491,3381,2361,8772,5931,700
Common Stock
584584584584584584
Additional Paid-In Capital
929.06929.06918.43915.66889.99896.7
Retained Earnings
2,4292,3182,8683,2522,7162,256
Treasury Stock
------44
Comprehensive Income & Other
6.926.99.1612.2814.3816.77
Total Common Equity
3,9493,8384,3794,7634,2053,709
Minority Interest
157.87152.37210.86241.25234225.72
Shareholders' Equity
4,1063,9914,5905,0054,4393,935
Total Liabilities & Equity
5,3565,3285,8266,8827,0325,635
Total Debt
111115.938.9926.52436.08244.08
Net Cash (Debt)
2,5632,4922,2893,5763,4112,049
Net Cash Growth
7.12%8.85%-35.97%4.82%66.47%37.72%
Net Cash Per Share
4.414.253.916.135.823.52
Filing Date Shares Outstanding
580.45584584584584587.54
Total Common Shares Outstanding
580.45584584584584587.54
Working Capital
2,4932,3502,8583,2682,6862,140
Book Value Per Share
6.806.577.508.167.206.31
Tangible Book Value
3,5843,4693,9604,3263,7463,264
Tangible Book Value Per Share
6.175.946.787.416.425.56
Buildings
-1,5651,5671,6121,6041,589
Machinery
-1,1451,1211,0751,014982.56
Construction In Progress
-32.3630.8435.730.2919.15